Demant A/S (CPH:DEMANT)
Denmark · Delayed Price · Currency is DKK 278.40
+0.60 (0.22%)
Jul 20, 2026, 4:59 PM CET
Demant Market Cap
Demant has a market cap or net worth of 58.59 billion as of July 20, 2026. Its market cap has increased by 1.12% in one year.
Market Cap
58.59B
Enterprise Value
78.32B
Revenue
22.97B
Ranking
n/a
PE Ratio
24.80
Stock Price
278.40
ChartMarket Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 58.59B, an increase of 2,664.94%. That is a compound annual growth rate of 11.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 58.59B | 27.81% |
| Dec 30, 2025 | 45.84B | -20.30% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.46T |
| Genmab | 114.74B |
| Coloplast | 95.20B |
| ALK-Abelló | 53.18B |
| H. Lundbeck | 41.26B |
| Zealand Pharma | 20.75B |
| Ambu A/S | 18.23B |
| Bavarian Nordic | 14.06B |